-
IAM share price: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
IAM stock price change: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
IAM market open/close: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
Key terms
About IAM
Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded by Thomas Miller and Fred Manby on October 14, 2019 and is headquartered in San Diego, CA.
-
IAM market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.
Key terms
Smart score
Latest IAM news
No recent TipRanks articles are available for IAM
No recent press releases are available for IAM
IAM Financials
-
IAM total revenue: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
IAM net income: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
-
IAM earnings per share: temporarily unavailable. We are sorry, but this information is temporarily unavailable.
Key terms
IAM Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
IAM Competitors
-
How competitors are chosen
IAM's competitors are included in the Technology Services sector and Packaged Software group
-
IAM market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.
